Stephens and colleagues from the International Cancer Genome Consortium [91] reported a separate WES analysis of 79 ER+ and 21 ER-negative BCs that confirmed the well-established somatic mutations in AKT1, CDH1, GATA3, PIK3CA, PTEN, RB1 and TP53. This evidence concerns the gene TP53 and cancer.